Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 2Peripheral Nervous System Diseases 1Ototoxicity 1Neoplasms, Cystic, Mucinous, and Serous 1Hearing Loss, Sensorineural 1Hearing Loss 1Head and Neck Neoplasms 1Ear Diseases 1Deafness 1Carcinoma, Hepatocellular 1Adenocarcinoma, Mucinous 1

Interventions

Acupuncture Therapy 3Paclitaxel 2Dexamethasone 2Cryotherapy 2Bortezomib 2XELOX 1Taxoids 1Sodium Selenite 1Sodium Chloride 1Silymarin 1Saline Solution 1Low-Level Light Therapy 1Glutamine 1G(M1) Ganglioside 1Folfox protocol 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Carboplatin 1Bevacizumab 1Amplified Fragment Length Polymorphism Analysis 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Peripheral Nervous System Diseases × Acetylcysteine × Clear all
NCT06297369 2024-03-07

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Ain Shams University

Phase 2 Unknown
60 enrolled

Ototoxicity, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡